Last edition
News about "ADC manufacturing"
Cohance Lifesciences to Invest USD 10 Million to Expand cGMP Bioconjugation Capabilities in US
Cohance Lifesciences will invest USD 10 million to expand cGMP bioconjugation capabilities at its US-based subsidiary NJ Bio, strengthening its integrated Antibody-Drug Conjugate manufacturing capacity for global innovators.
ADC Manufacturing | 13/08/2025 | By Mrinmoy Dey | 162
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members